The Calmer Co International Ltd (ASX:CCO) Share Price

Company Profile

Business description
The Calmer Co International Ltd is mainly engaged in the research, development, and selling of kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and via its Farm located in Fiji and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its reportable segments are; Fiji Kava Australia Trading Pty Ltd (Fiji Kava Australia Trading) which derives maximum revenue, South Pacific Elixirs Pty Limited (SPE Fiji), Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA). Geographically, it derives key revenue from Australia and the rest from Fiji, and other regions.
Contact
96 Victoria Street
West End
BrisbaneQLD4101
AUS
T: +61 738441010
https://www.thecalmerco.com
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
30 June 2026
Employees

Recommended

As investors toil in complexity the obvious solution may be the right one.

Mark LaMonica, CFA | 24 July 2025

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.

Matthew Dolgin, CFA | 23 July 2025

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

John Abernethy | 23 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,937.50	41.90	-0.47%
CAC 40	7,818.28	32.15	-0.41%
DAX 40	24,295.93	55.11	0.23%
Dow JONES (US)	44,693.91	316.38	-0.70%
FTSE 100	9,138.37	76.88	0.85%
HKSE	25,383.07	284.11	-1.11%
NASDAQ	21,057.96	37.94	0.18%
Nikkei 225	41,450.36	375.98	-0.90%
NZX 50 Index	12,855.10	49.97	0.39%
S&P 500	6,363.35	4.44	0.07%
S&P/ASX 200	8,670.10	39.30	-0.45%
SSE Composite Index	3,593.38	12.35	-0.34%